MCX Share: Buying of shares has started, UBS said- if you invest money then you will get 22% return easily:

News Topical, Digital Desk : The stock of Multi Commodity Exchange of India Limited (MCX) is witnessing a rise of more than 3% today. Global brokerage firm UBS has recommended 'Buy' on MCX stock and increased its target price to ₹ 10,000, which was earlier ₹ 7,000. This target is about 22% higher than the current market price of ₹ 8,222.

UBS's target is the highest target in the market so far. Earlier, HDFC Research had given a target of ₹ 9,040 and ICICI Securities had given a target of ₹ 8,800.

Why did UBS's confidence increase?
UBS's report says that there are many important reasons behind MCX's growth. Trading volume is increasing due to increased volatility in major commodities. Apart from this, the average volume of MCX's futures trading in the first quarter was 50% higher than the previous quarter. Options premium also increased by 30%. Clarity of new product launch: The company has shown better planning and execution regarding new products, which has increased confidence about future growth. In view of these positive signs, UBS has improved the estimated earnings of FY27 and FY28 by 13-17%. Brokerage rating on MCX

Brokerage	Rating	Target Price
UBS	Buy	₹10,000
HDFC Research	Buy	₹9,040
ICICI Securities	Buy	₹8,800

According to Bloomberg, 11 analysts have included MCX in their coverage list. Out of these, 7 analysts have advised to buy the stock. Whereas, 3 analysts have given a Hold opinion on the stock. At the same time, 1 analyst has given a Sell opinion on the stock. On Tuesday, MCX shares closed at ₹ 8,222, with a gain of 0.84%. In the last one month, the stock has climbed up to 27%, while the market continued to fluctuate.